SBNO2 and gastric cancer: Similarly, subtype analysis of gastric pathology was performed, and increased SBNO2 mRNA expression was associated with intestinal GC (HR = 2.31, 95%CI = 1.67–3.21, P < 0.001) but not with diffuse GC (HR = 1.29, 95%CI = 0.92–1.82, P = 0.14; Figures 5(i) and 5(j)).